| Fonds | 2026/Q1 | 2025/Q4 | 2025/Q3 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | |
| 350.106.920 $ | -132.056.365 $ | -18,6 % | 681.825.313 $ | +162.691.476 $ | +34,0 % | 511.368.686 $ | +123.920.814 $ | +41,3 % | |
| Frazier Life Sciences Management, L.P. | 138.502.693 $ | -68.316.360 $ | -33,0 % | 206.819.053 $ | +60.088.477 $ | +41,0 % | 146.730.576 $ | +27.176.946 $ | +22,7 % |
| Medicxi Ventures Management (Jersey) Ltd | 82.931.395 $ | -40.905.854 $ | -33,0 % | 123.837.249 $ | +35.979.237 $ | +41,0 % | 87.858.012 $ | +16.272.767 $ | +22,7 % |
| MILLENNIUM MANAGEMENT LLC | 44.694.519 $ | +10.151.153 $ | +29,4 % | 34.543.366 $ | -25.265.312 $ | -42,2 % | 59.808.678 $ | +38.226.412 $ | +177,1 % |
| BlackRock, Inc. | 45.128.776 $ | -13.857.764 $ | -23,5 % | 58.986.540 $ | +18.941.186 $ | +47,3 % | 40.045.354 $ | +8.251.167 $ | +26,0 % |
| Carlyle Group Inc. | 38.849.537 $ | -19.127.540 $ | -33,0 % | 57.977.077 $ | +16.924.551 $ | +41,2 % | 41.052.526 $ | +7.518.137 $ | +22,4 % |
| VANGUARD GROUP INC | 52.709.931 $ | +14.862.649 $ | +39,3 % | 37.847.282 $ | +11.116.969 $ | +41,6 % | |||
| Invesco Ltd. | 45.490.710 $ | +5.787.420 $ | +14,6 % | ||||||
| Ensign Peak Advisors, Inc | 39.020.012 $ | +9.555.653 $ | +32,4 % | 29.464.359 $ | +5.297.828 $ | +21,9 % | |||
| NEA Management Company, LLC | 32.519.204 $ | +9.448.015 $ | +41,0 % | 23.071.189 $ | +4.273.168 $ | +22,7 % | |||
| 683 Capital Management, LLC | 29.613.150 $ | +8.187.277 $ | +38,2 % | ||||||
| Catalys Pacific, LLC | 23.707.342 $ | +9.970.410 $ | +72,6 % | ||||||
| WASATCH ADVISORS LP | 22.092.389 $ | +3.999.333 $ | +22,1 % | ||||||
| 350.106.920 $ | -132.056.365 $ | -18,6 % | 681.825.313 $ | +162.691.476 $ | +34,0 % | 511.368.686 $ | +123.920.814 $ | +41,3 % | |